Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

Phase 3

Completed

Conditions: Spinal Metastases

Interventions: Radiation: single-fraction SRS
Radiation: high-dose hypofractionated SRS
Behavioral: Quality of Life Measures

First Posted Date: 2014-12-19

Last Posted Date: 2019-02-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT02320825

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States

and more 1 locations

Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

Phase 1

Recruiting

Conditions: Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL)
Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Interventions: Drug: Ibrutinib
Drug: HD- Methotrexate (MTX)
Drug: Rituximab + HD- Methotrexate (MTX)
Drug: procarbazine

First Posted Date: 2014-12-11

Last Posted Date: 2024-12-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 109

Registration Number: NCT02315326

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: multi-parametric MRI(MP-MRI)
Device: dynamic contrast-enhanced MRI (DCE)
Procedure: biopsy

First Posted Date: 2014-12-09

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT02312401

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 5 locations

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

Active, not recruiting

Conditions: Breast Cancer Screening

Interventions: Device: contrast enhanced digital mammography (CEDM)
Device: whole breast screening ultrasound (WBUS)

First Posted Date: 2014-12-08

Last Posted Date: 2024-08-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 487

Registration Number: NCT02310698

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

Phase 1

Completed

Conditions: T-cell Lymphoma
Relapsed and Refractory T-cell Lymphoma

Interventions: Drug: Ibrutinib

First Posted Date: 2014-12-05

Last Posted Date: 2023-05-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02309580

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

Not Applicable

Active, not recruiting

Conditions: Neuroblastoma
Melanoma
Sarcoma

Interventions: Biological: 124I-Humanized 3F8

First Posted Date: 2014-12-04

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT02307630

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Not Applicable

Completed

Conditions: Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Human Papillomavirus (HPV)-Related Malignancies

Interventions: Drug: Ribavirin

First Posted Date: 2014-12-04

Last Posted Date: 2023-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT02308241

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

Yoga Practice for Breast or Ovarian Cancer Patients

Not Applicable

Completed

Conditions: Ovarian Cancer
Breast Cancer

Interventions: Other: Vigorous yoga practice
Other: Restorative (gentle) yoga practice

First Posted Date: 2014-12-02

Last Posted Date: 2019-03-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT02305498

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2014-11-26

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2187

Registration Number: NCT02301767

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing

Terminated

Conditions: Colon Cancer

Interventions: Other: Usual care
Other: Phone Calls

First Posted Date: 2014-11-25

Last Posted Date: 2017-03-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT02301338

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy